VIRATEK's VIRAZOLE FOR SEVERE LOWER RESPIRATORY INFECTIONS IS TARGETED AT APPROXIMATELY 100,000 YOUNG CHILDREN PER YEAR; FDA APPROVES ANTIVIRAL DRUG JAN. 2

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".